Ownership

Stephen Berenson

Insider Reports History

Entity: Individual
Location: C/O Flagship Pioneering, Inc., 55 Cambridge Parkway, Ste 800 E, Cambridge, MA
Signature: /s/ Thomas J. DesRosier, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Berenson:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Moderna, Inc.	Director	Common Stock	22.2K	$2.52M	$113.40	May 3, 2024	Direct
Moderna, Inc.	Director	Restricted Stock Units	0	$0	$113.40	May 3, 2024	Direct
Seres Therapeutics, Inc.	Director	Stock Option (Right to Buy)	115K			Jul 1, 2024	Direct
Moderna, Inc.	Director	Stock Option (Right to Buy)	7.56K			May 6, 2024	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Stephen Berenson

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
MCRB	Seres Therapeutics, Inc.	Jul 1, 2024	1	$0	4	Jul 3, 2024	Director
MRNA	Moderna, Inc.	May 3, 2024	3	$0	4	May 7, 2024	Director
MCRB	Seres Therapeutics, Inc.	Apr 4, 2024	1	$0	4	Apr 8, 2024	Director
MCRB	Seres Therapeutics, Inc.	Jun 22, 2023	1	$0	4	Jun 23, 2023	Director
MRNA	Moderna, Inc.	May 3, 2023	2	$0	4	May 5, 2023	Director
MRNA	Moderna, Inc.	Apr 28, 2023	2	$0	4	May 1, 2023	Director
MCRB	Seres Therapeutics, Inc.	Jun 22, 2022	1	$0	4	Jun 24, 2022	Director
MRNA	Moderna, Inc.	Apr 28, 2022	4	$0	4	May 2, 2022	Director
MRNA	Moderna, Inc.	Aug 19, 2021	1	$0	4	Aug 20, 2021	Director
MCRB	Seres Therapeutics, Inc.	Jun 16, 2021	1	$0	4	Jun 21, 2021	Director